GLP-1
Tirzepatide vs. Semaglutide: The Definitive 2026 Head-to-Head Comparison
Two injectable medications are reshaping obesity medicine: tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy). Both belong to the GLP-1 drug class, both are once-weekly injections, and both produce clinically meaningful weight loss. But the similarities mostly end there. In May 2025, the landmark SURMOUNT-5 trial published in the New England